Sleep Apnea Syndromes

1
Pipeline Programs
1
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

R
ResMedCA - San Diego
2 programs
1
APAP - TherapyPhase 31 trial
Fixed CPAPN/A1 trial
Active Trials
NCT03428516Completed57Est. Nov 2022
NCT01303198Unknown60Est. Apr 2011

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ResMedAPAP - Therapy
ResMedFixed CPAP

Clinical Trials (2)

Total enrollment: 117 patients across 2 trials

NCT01303198ResMedAPAP - Therapy

Autoset T Versus CPAP Therapy, a Comparison of Titration and Therapy

Start: Jun 2001Est. completion: Apr 201160 patients
Phase 3Unknown

Decrease Obstructive Sleep Apnea (OSA) Sympathetic Tone : Impact of APAP vs CPAP

Start: Mar 2018Est. completion: Nov 202257 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
1 companies competing in this space